From global vaccines to personalized cancer therapies, mRNA is being considered across several clinical applications, which ultimately creates varying requirements in terms of production scale and ...
In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...
Stay ahead in the booming mRNA market, projected to reach $63.28 billion by 2025, with the 3 rd mRNA Process Development & Manufacturing Summit 2025—Europe’s premier industry-focused forum dedicated ...
Moderna's $140 million investment in Norwood, Massachusetts, aims to complete its U.S. manufacturing loop, enhancing ...
RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.
In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new vaccines has become crucial. However, the speed of vaccine production is ...
The mRNA vaccine raw materials market offers opportunities in supply chain agility and specialized component sourcing. Growth is driven by demand for pandemic solutions, regulatory shifts, and ...
Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...
In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and ...
The experimental mRNA vaccine prevented 60% to 67% of flu infections, while the conventional vaccine prevented 44% to 54% of ...
Health and Human Services Secretary Robert F. Kennedy Jr. speaks as President Donald Trump listens at an event to promote his proposal to improve Americans’ access to their medical records in the East ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback